HC Wainwright & Co. Initiates Coverage On ImageneBio with Buy Rating, Announces Price Target of $28

Benzinga · 3d ago
HC Wainwright & Co. analyst Arthur He initiates coverage on ImageneBio (NASDAQ:IMA) with a Buy rating and announces Price Target of $28.